Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zafirlukast in Moderate COVID-19
NCT04871828Phase 3Unknown
- Sponsor
- King Abdullah International Medical Research Center
- Start
- Feb 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zafirlukast in coronavirus disease 2019 (COVID-19), sponsored by King Abdullah International Medical Research Center. Status: unknown.
02
Drugs
zafirlukast
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04871828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04871828.